OrbiMed Capital GP VIII LLC's Net Worth

-$4.67 Million

Who is OrbiMed Capital GP VIII LLC?

OrbiMed Capital GP VIII LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ArriVent Biopharma, Inc., Janux Therapeutics, Inc., Decibel Therapeutics, Inc., Kinnate Biopharma Inc., and Disc Medicine, Inc..

SEC CIK

OrbiMed Capital GP VIII LLC's CIK is 0001845804

Past Insider Trading and Trends

2023 was OrbiMed Capital GP VIII LLC's most active year for acquiring shares with 19 total transactions. OrbiMed Capital GP VIII LLC's most active month to acquire stocks was the month of April. 2023 was OrbiMed Capital GP VIII LLC's most active year for disposing of shares, totalling 11 transactions. OrbiMed Capital GP VIII LLC's most active month to dispose stocks was the month of November. 2021 saw OrbiMed Capital GP VIII LLC paying a total of $41,999,489.00 for 7,987,956 shares, this is the most they've acquired in one year. In 2023 OrbiMed Capital GP VIII LLC cashed out on 567,400 shares for a total of $32,486,366.00, their largest year based on trade value.